GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Turmeric Acquisition Corp (NAS:TMPMU) » Definitions » EBITDA Margin %

Turmeric Acquisition (Turmeric Acquisition) EBITDA Margin % : 0.00% (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Turmeric Acquisition EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Turmeric Acquisition's EBITDA for the three months ended in Jun. 2022 was $-0.20 Mil. Turmeric Acquisition's Revenue for the three months ended in Jun. 2022 was $0.00 Mil. Therefore, Turmeric Acquisition's EBITDA margin for the quarter that ended in Jun. 2022 was 0.00%.


Turmeric Acquisition EBITDA Margin % Historical Data

The historical data trend for Turmeric Acquisition's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turmeric Acquisition EBITDA Margin % Chart

Turmeric Acquisition Annual Data
Trend Dec20 Dec21
EBITDA Margin %
- -

Turmeric Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EBITDA Margin % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Turmeric Acquisition's EBITDA Margin %

For the Shell Companies subindustry, Turmeric Acquisition's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Turmeric Acquisition's EBITDA Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Turmeric Acquisition's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Turmeric Acquisition's EBITDA Margin % falls into.



Turmeric Acquisition EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Turmeric Acquisition's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=2.655/0
= %

Turmeric Acquisition's EBITDA Margin % for the quarter that ended in Jun. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2022 )/Revenue (Q: Jun. 2022 )
=-0.2/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turmeric Acquisition  (NAS:TMPMU) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Turmeric Acquisition EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Turmeric Acquisition's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Turmeric Acquisition (Turmeric Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
450 Kendall Street, Cambridge, MA, USA, 02142
Turmeric Acquisition Corp is a blank check company.
Executives
Luke Evnin officer: Chief Executive Officer THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH STREET, BOSTON MA 02116
Mitchell H. Finer director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Edward Hurwitz officer: Chief Financial Officer
Todd Foley officer: President THE JOHN HANCOCK TOWER, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Pablo J Cagnoni director ONYX PHARMACEUTICALS, INC., 249 E. GRAND AVE., SOUTH SAN FRANCISCO CA 94080
David P Meeker director C/O PENWEST PHARMACEUTICALS CO, 39 OLD RIDGEBURY ROAD SUITE 11, DANBURY CT 06810
Andrew R Robbins director C/O 3200 WALNUT ST, BOULDER CO 80301
Matthew Roden director 450 KENDALL STREET, CAMBRIDGE MA 02142
Turmeric Management, Llc 10 percent owner 450 KENDALL STREET, CAMBRIDGE MA 02142
Vinay Bhaskar officer: Chief Operating Officer 2000 SIERRA POINT PARKWAY, SUITE 701, BRISBANE CA 94005